Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne – With first patient dosed in Phase III clinical trial, Ascletis’ strategic… CISION PRNewswireOctober 23, 2026
Scage Future Announces Effective Date for ADS Ratio Change NANJING, China, Oct. 23, 2026 /PRNewswire/ — Scage Future ("Scage Future" or… CISION PRNewswireOctober 23, 2026
Harbour BioMed Receives China NMPA Approval of Batoclimab Injection (Subcutaneous Injection) for the Treatment of Generalized Myasthenia Gravis The first NMPA-approved anti-FcRn therapy to complete its full clinical development for… CISION PRNewswireOctober 23, 2026
Seatrium and Karpowership Sign Contract for a Series of Whale Class Powership Conversion and Integration Projects SINGAPORE, Oct. 23, 2026 /PRNewswire/ — Seatrium Limited and its strategic partner, floating… CISION PRNewswireOctober 23, 2026
Seatrium and Karpowership Sign Contract for a Series of Whale Class Powership Conversion and Integration Projects SINGAPORE, Oct. 23, 2026 /PRNewswire/ — Seatrium Limited and its strategic partner, floating… CISION PRNewswireOctober 23, 2026
ImmVira Presents Clinical Data from Three Bladder Cancer Studies at ESMO 2026 SUZHOU, China, Oct. 23, 2026 /PRNewswire/ — ImmVira Group ("ImmVira") today announced… CISION PRNewswireOctober 23, 2026
Press Release Hanwha Power Receives ABS Approval in Principle for 1,700 TEU Battery-Powered Containership Design Fully electric propulsion design featuring approximately 151 MWh of energy storage strengthens… CISION PRNewswireOctober 23, 2026
Press Release Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety WUHU, China, Oct. 23, 2026 /PRNewswire/ — On 22 October 2026, CHERY held… CISION PRNewswireOctober 23, 2026
